Status:
UNKNOWN
Vitamin D on Prevention and Treatment of COVID-19
Lead Sponsor:
Universidad de Granada
Conditions:
Patients Infected With COVID-19
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The new outbreak of the SARS-CoV-2 coronavirus is causing an important pandemic affecting a large number of people all-over the world. Vitamin D is a hormone precursor produced by our own body with th...
Eligibility Criteria
Inclusion
- Non-severe symptomatic patients who present cough, fever, nasal congestion, gastrointestinal symptoms, fatigue, anosmia, ageusia or alternative signs of respiratory infections.
Exclusion
- Patients presenting severe respiratory and/or multisystemic symptoms compatible with advanced COVID-19 and intercurrent acute or severe chronic diseases (i.e. active cancer).
Key Trial Info
Start Date :
April 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04334005
Start Date
April 10 2020
End Date
June 30 2020
Last Update
April 7 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad de Granada
Granada, Andalusia, Spain, 18071
2
Medicine Faculty
Granada, Spain, 18001